Approval · Notice of Compliance 980 · 2000
TENORETIC: Notice of Compliance 980
Issued February 15, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 980
- Date
- February 15, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antihypertensive agent
Products in this notice
Medicinal ingredients
- ATENOLOL 50 MG per TAB
- CHLORTHALIDONE 25 MG per TAB
- ATENOLOL 100 MG per TAB